سرترالين تيڤع ٥٠ ملغ
Country: Iżrael
Lingwa: Għarbi
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
SERTRALINE AS HYDROCHLORIDE 50 MG
Disponibbli minn:
TEVA PHARMACEUTICAL INDUST.LTD
Kodiċi ATC:
N06AB06
Għamla farmaċewtika:
TABLETS
Rotta amministrattiva:
PER OS
Manifatturat minn:
TEVA PHARMACEUTICAL INDUSTRIES LTD
Grupp terapewtiku:
SERTRALINE
Indikazzjonijiet terapewtiċi:
For the treatment of symptoms of depression in patients with or without a history of mania. Following satisfactory response, continuation with sertaline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.
Data ta 'l-awtorizzazzjoni:
2009-11-01
